Neuroprotective effects of Moringa oleifera: Bio-guided GC-MS identification of active compounds in diabetic neuropathic pain model
- 112 Downloads
To explore the phytotherapeutic-activities of Moringa oleifera (MO) seeds on painful diabetic neuropathy in alloxan-induced diabetic mice.
The bio-guided fractionation of MO utilizing column chromatography aided with GC-MS was used to detect the most active constituent of MO. Hyperalgesia, using tail-flick and hot-plate latency experiments, and mechanical-allodynia, utilizing von-Frey filaments, were evaluated before and after 8 weeks of intraperitoneal alloxan administration (180 mg/kg). Serum catalase and insulin levels, body weight and blood glucose levels (BGL), alpha-glucosidase inhibition, lipid peroxidation and glycated hemoglobin (HbA1c) were measured to evaluate both alloxan-induced diabetes mellitus and diabetic painful neuropathy (DPN).
Beta-sitosterol (BSL) was proved to be the most active constituent of MO. The administration of MO (40, 60 and 80 mg/kg) or BSL (18, 25 and 35 mg/kg) significantly attenuated hyperalgesia and tactile allodynia (P⩽0.05), compared with tramadol (10 mg/kg) acting as a positive control, in alloxan-treated animals (n=7 per group). Moreover, MO and BSL have improved insulin secretion, in vivo antioxidant catalase, lipid peroxidation, acute and subchronic BGL, and normalized alpha-glucosidase and HbA1c levels.
The observed insulin secretagogue, alpha-glucosidase inhibition, hypoglycemic and antioxidant potentials might be responsible for MO and BSL antinociception and neuroprotective mechanism. MO and BSL have shown good glycemic-control and powerful neuroprotective properties which might serve as potential lead-compounds for further analysis.
KeywordsMoringa oleifera beta-sitosterol in vivo antioxidant alpha-glucosidase glycated hemoglobin diabetic neuropathy
Unable to display preview. Download preview PDF.
Authors would like to thank Mrs. G. Onsy (BAU, Lebanon) for proof-reading the manuscript.
- 6.Adam SH, Giribabu N, Kassim N, Kumar KE, Brahmayya M, Arya A, et al. Protective effect of aqueous seed extract of Vitis Vinifera against oxidative stress, infl ammation and apoptosis in the pancreas of adult male rats with diabetes mellitus. Biomed Pharmacother 2016;81:439–452.CrossRefPubMedGoogle Scholar
- 7.Raafat KM, Jassar H, Aboul-Ela M, El-Lakany A. Protective effects of Origanum majorana L. against neurodegeneration: fingerprinting, isolation and in vivo glycine receptors behavioral model. Int J Phytomed 2013;5:46–57.Google Scholar
- 9.Raafat K, Aboul-Ela M, El-Lakany A. Alloxan-induced diabetic thermal hyperalgesia, prophylaxis and phytotherapeutic effects of Rheum ribes L. in mouse model. Arch Pharm Res 2014:1–10.Google Scholar
- 18.Biswas S, Chowdhury A, Das J, Roy A, Zahid M. Pharmacological potentials of Moringa oleifera Lam.: a review. Int J Pharm Sci Res 2012;3:305–310.Google Scholar
- 21.Jimenez-Suarez V, Nieto-Camacho A, Jimenez-Estrada M, Alvarado Sanchez B. Anti-infl ammatory, free radical scavenging and alpha-glucosidase inhibitory activities of Hamelia patens and its chemical constituents. Pharm Biol 2016:1–9.Google Scholar
- 35.World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: World Health Organization; 2007.Google Scholar
- 36.da Silva AR, Moreira Lda R, Brum Eda S, de Freitas ML, Boligon AA, Athayde ML, et al. Biochemical and hematological effects of acute and sub-acute administration to ethyl acetate fraction from the stem bark Scutia buxifolia Reissek in mice. J Ethnopharmacol 2014;153:908–916.CrossRefPubMedGoogle Scholar
- 40.Ranilla LG, Kwon YI, Apostolidis E, Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour Technol 2010;101:4676–4689.CrossRefPubMedGoogle Scholar
- 42.Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain sev. Pain sev. Pain sev. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374–385.CrossRefPubMedGoogle Scholar